What Is Driving Global Drug Discovery Services Market Growth in 2025: The Role of The Surge In Drug Discovery Trials Ignites Growth In The Drug Discovery Services Market

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Drug Discovery Services Market Size Growth Forecast: What to Expect by 2025?
The sphere of drug discovery services has witnessed substantial expansion lately, projected to increase its market valuation from $18.27 billion in 2024 to $20.52 billion in the subsequent year, reflecting a compound annual growth rate (CAGR) of 12.3 percent; this prior period's upward trajectory is primarily fueled by greater outlays on research and development, the rising prevalence of various illnesses, financial aid and backing from governmental bodies, the proliferation of contract research organizations, a pivot toward customized medical treatments, and the utilization of drug repurposing methodologies.

How Will the Drug Discovery Services Market Size Evolve and Grow by 2029?
Anticipation surrounds the drug discovery services sector, projecting substantial expansion over the impending years, specifically escalating to a market valuation of $34.38 billion by 2029, underpinned by a compound annual growth rate (CAGR) of 13.8%. This trajectory of upward movement during the projection timeframe is fueled by several key factors, including modifications within the regulatory landscape, progress in methods of drug administration, heightened engagement with immunotherapy approaches, a pivot toward therapies based on RNA, and a greater emphasis on addressing uncommon medical conditions. Furthermore, prominent patterns shaping this period encompass the integration of cutting-edge technologies, the burgeoning expansion of biologicals and biopharmaceuticals, the broader implementation of high-throughput screening techniques, sophistication in virtual screening methodologies, and a concentrated effort towards regenerative medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

What Drivers Are Propelling the Growth of Drug Discovery Services Market Forward?
An intensified concentration on preclinical and early-stage testing operations is anticipated to give momentum to the market for drug discovery support services. The entire sequence of bringing a new medicine from concept to patient, known as the drug development lifecycle, is paramount for guaranteeing that therapeutic agents are both safe and efficacious when administered. Consequently, rigorous clinical investigations are ascending in significance as an indispensable segment of the overall process of advancing new medical treatments. As innovation in pharmaceuticals and the broader importance of developing novel drugs within healthcare escalate, there has been a corresponding surge in the global requirement for drug discovery research efforts. To illustrate this trend, data from ClinicalTrials.gov, the central registry for such studies, indicated that by May 2023, the cumulative number of registered clinical trials had reached 452,604, marking a notable rise from the 365,000 trials recorded just two years prior in 2021; thus, this expanding commitment to drug discovery testing is poised to fuel the expansion of the commercial services supporting these initial research phases.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8324&type=smp

Which Emerging Trends Are Transforming the Drug Discovery Services Market in 2025?
Key players within the domain of drug discovery services are actively incorporating sophisticated technological advancements, specifically artificial intelligence and machine learning, aiming to boost both the effectiveness and precision of the entire drug development pipeline. These two disciplines, AI and ML, are intricately linked areas within computational science; AI broadly encompasses creating computer systems capable of executing functions traditionally needing human cognitive ability, while ML constitutes a specialized branch of AI concentrating on employing algorithms and statistical frameworks which allow machines to derive insight or generate forecasts from available data. As a concrete example, in February of 2024, Eurofins Discovery, a firm situated in France that offers supportive solutions across numerous industries like pharmaceuticals, unveiled a novel solution named DiscoveryAI SAFIRE (Suite of ADMET Predictions for In Silico Refinement and Evaluation); this cutting-edge tool employs proprietary data collections along with AI and ML methodologies to improve preclinical drug development, specifically focusing on accelerating the identification of novel therapeutic agents by forecasting the ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) characteristics of chemical compounds, benefiting significantly from the vast, long-term accumulated knowledge within Eurofins Discovery's proprietary BioPrint database.

What Are the Key Segments in the Drug Discovery Services Market?
The drug discovery servicesmarket covered in this report is segmented -

1) By Type: Chemistry Services; Biology Services
2) By Process: Target Selection; Target Validation; Hit-To-Lead identification; Lead Optimization; Candidate Validation
3) By Drug Type: Biologics Drug ; Small Molecule Drug
4) By End user: Pharmaceutical And Biotechnology Companies; Academic Institutes; Other End Users

Subsegments:
1) By Chemistry Services: Medicinal Chemistry; Compound Management; High-Throughput Screening; Lead Optimization
2) By Biology Services: In Vitro Studies; In Vivo Studies; Pharmacokinetics And Pharmacodynamics (PK Or PD); Biomarker Discovery

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8324&type=smp

Who Are the Key Players Shaping the Drug Discovery Services Market's Competitive Landscape?
Major companies operating in the drug discovery services market are Thermo Fisher Scientific Inc., Albany Molecular Research Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, Domainex Ltd., GenScript Biotech Corporation, Pharmaceutical Product Development LLC, Advinus Therapeutics Pvt. Ltd., Jubilant Biosys Ltd., Evotec AG, Syngene International Ltd., Bayer AG, Merck KGaA, Ubiquigent Ltd., Eurofins Scientific SE, AppTec Laboratory Services Inc., GVK Biosciences Private Limited, Aurigene Discovery Technologies Limited, Viva Biotech Holdings, Pharmaron Beijing Co. Ltd., Selcia Limited, Concept Life Sciences Group Limited, BioDuro LLC, ChemPartner Corporation, Aptuit LLC, Sygnature Discovery Limited, Peak Proteins Ltd., SRI International, BioAscent Discovery Limited, Sai Life Sciences Limited, Promega Corporation, MedChemExpress LLC, Aragen Bioscience Inc., WuXi STA, BioNTech SE, Moderna Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals Inc., Amgen Inc., Bristol-Myers Squibb Company

What Geographic Markets Are Powering Growth in the Drug Discovery Services Market?
North America was the largest region in the drug discovery services market in 2024. The regions covered in the drug discovery services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8324

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.